Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin.

[1]  F. Kronenberg,et al.  Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study. , 2006, Journal of the American College of Cardiology.

[2]  E. Brilakis,et al.  Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. , 2005, The New England journal of medicine.

[3]  J. Witztum,et al.  Thematic review series: The Immune System and Atherogenesis. The role of natural antibodies in atherogenesis Published, JLR Papers in Press, May 16, 2005. DOI 10.1194/jlr.R500005-JLR200 , 2005, Journal of Lipid Research.

[4]  S. Young,et al.  High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins. , 2005, Journal of lipid research.

[5]  J. Berliner,et al.  A role for oxidized phospholipids in atherosclerosis. , 2005, The New England journal of medicine.

[6]  G. Dahlén,et al.  Changes in Lp(a) lipoprotein levels during the treatment of hypercholesterolaemia with simvastatin , 2005, European Journal of Clinical Pharmacology.

[7]  K. Lackner,et al.  Reduced In Vivo Aortic Uptake of Radiolabeled Oxidation-Specific Antibodies Reflects Changes in Plaque Composition Consistent With Plaque Stabilization , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[8]  Y. Shoenfeld,et al.  Are Anti–Oxidized Low-Density Lipoprotein Antibodies Pathogenic or Protective? , 2004, Circulation.

[9]  W. Sasiela,et al.  High-Dose Atorvastatin Reduces Total Plasma Levels of Oxidized Phospholipids and Immune Complexes Present on Apolipoprotein B-100 in Patients With Acute Coronary Syndromes in the MIRACL Trial , 2004, Circulation.

[10]  H. Büller,et al.  Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study , 2004, JAMA.

[11]  B. Strauss,et al.  Percutaneous Coronary Intervention Results in Acute Increases in Oxidized Phospholipids and Lipoprotein(a): Short-Term and Long-Term Immunologic Responses to Oxidized Low-Density Lipoprotein , 2004, Circulation.

[12]  Aldons J Lusis,et al.  Thematic review series: The Pathogenesis of Atherosclerosis Published, JLR Papers in Press, April 1, 2004. DOI 10.1194/jlr.R400001-JLR200 The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL , 2004, Journal of Lipid Research.

[13]  S. Rubin,et al.  The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. , 2004, Diabetes.

[14]  J. Witztum,et al.  Changes in Dietary Fat Intake Alter Plasma Levels of Oxidized Low-Density Lipoprotein and Lipoprotein(a) , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[15]  E. Sijbrands,et al.  Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia , 2004, The Lancet.

[16]  K. Chien.  Molecular Basis of Cardiovascular Disease: A companion to Braunwald's Heart Disease , 1999, Cardiovascular Drugs and Therapy.

[17]  G. Getz,et al.  Lysine-Phosphatidylcholine Adducts in Kringle V Impart Unique Immunological and Potential Pro-inflammatory Properties to Human Apolipoprotein(a)* , 2003, Journal of Biological Chemistry.

[18]  V. Lelyveld,et al.  A Single Protease, Apg4B, Is Specific for the Autophagy-related Ubiquitin-like Proteins GATE-16, MAP1-LC3, GABARAP, and Apg8L* , 2003, Journal of Biological Chemistry.

[19]  M. Päivänsalo,et al.  Immunoglobulin M Type of Autoantibodies to Oxidized Low-Density Lipoprotein Has an Inverse Relation to Carotid Artery Atherosclerosis , 2003, Circulation.

[20]  P. Ridker,et al.  Antioxidant Vitamins C and E Improve Endothelial Function in Children With Hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial , 2003, Circulation.

[21]  B. McCrindle,et al.  Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. , 2003, The Journal of pediatrics.

[22]  Joseph Juliano,et al.  Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. , 2003, Journal of the American College of Cardiology.

[23]  Nordin Fredrikson.  Plasma oxidized LDL: a predictor for acute myocardial infarction? , 2003 .

[24]  J. Kastelein,et al.  Early statin therapy restores endothelial function in children with familial hypercholesterolemia. , 2002, Journal of the American College of Cardiology.

[25]  H. Koyama,et al.  Antibody to oxidized low-density lipoprotein and cardiovascular mortality in end-stage renal disease. , 2002, Kidney international.

[26]  J. Witztum,et al.  Shifting the diagnosis and treatment of atherosclerosis to children and young adults: a new paradigm for the 21st century. , 2002, Journal of the American College of Cardiology.

[27]  J. Witztum,et al.  Innate and acquired immunity in atherogenesis , 2002, Nature Medicine.

[28]  M. Mercuri,et al.  Efficacy and Safety of Statin Therapy in Children With Familial Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled Trial With Simvastatin , 2002, Circulation.

[29]  E. Schaefer,et al.  Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects. , 2002, The American journal of cardiology.

[30]  H. Horiguchi,et al.  Oxidized LDL in Carotid Plaques and Plasma Associates With Plaque Instability , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[31]  BjörnFagerberg,et al.  Circulating Oxidized LDL Is Associated With Subclinical Atherosclerosis Development and Inflammatory Cytokines (AIR Study) , 2002 .

[32]  B. McCrindle,et al.  A Randomized Crossover Trial of Combination Pharmacologic Therapy in Children with Familial Hyperlipidemia , 2002, Pediatric Research.

[33]  Olli T. Raitakari,et al.  Increased Aortic Intima-Media Thickness: A Marker of Preclinical Atherosclerosis in High-Risk Children , 2001, Circulation.

[34]  F. Van de Werf,et al.  Circulating Oxidized LDL Is a Useful Marker for Identifying Patients With Coronary Artery Disease , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[35]  J. Witztum,et al.  Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk. , 2001, Circulation.

[36]  T. Matsuo,et al.  Elevated Levels of Oxidized Low Density Lipoprotein Show a Positive Relationship With the Severity of Acute Coronary Syndromes , 2001, Circulation.

[37]  J. Berliner,et al.  Evidence for a role of phospholipid oxidation products in atherogenesis. , 2001, Trends in cardiovascular medicine.

[38]  M. Emoto,et al.  Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. , 2000, Atherosclerosis.

[39]  S. Kiechl,et al.  The natural course of atherosclerosis. Part I: incidence and progression. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[40]  P. Hopkins,et al.  Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. , 1999, JAMA.

[41]  J L Witztum,et al.  Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. , 1997, The Journal of clinical investigation.

[42]  G. Jerums,et al.  A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemia , 1997 .

[43]  G. Jerums,et al.  A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia. , 1997, The American journal of cardiology.

[44]  D. Betteridge,et al.  Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. , 1994, The Journal of clinical investigation.

[45]  J. K. Lloyd,et al.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis , 1992, The Lancet.

[46]  M. Weintraub,et al.  HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. , 1989, Circulation.

[47]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.